NHS (Neuberger High Yield Strategies Fund Inc.) Stock Analysis - AI Report
Neuberger High Yield Strategies Fund Inc. (NHS) is a publicly traded Financial Services sector company. As of May 21, 2026, NHS trades at $6.25 with a market cap of $197.31M and a P/E ratio of 0.00. NHS moved +0.56% today. Year to date, NHS is -15.88%; over the trailing twelve months it is -16.56%. Its 52-week range spans $6.13 to $8.67. Rallies surfaces NHS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on NHS?
Rallies AI research for NHS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
Kocinski Chris bought 6.00K (~$44.40K) on Jul 17, 2025.
Kocinski Chris bought 15.00K (~$111.60K) on May 29, 2025.
Lind Joseph bought 5.00K (~$45.71K) on Jun 7, 2022.
NHS Analyst Consensus
NHS analyst coverage data. Average price target: $0.00.
Common questions about NHS
What is the AI research view on NHS?
Rallies AI research for NHS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for NHS?
Rallies AI research for NHS combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is NHS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NHS. It does not provide personalized investment advice.